![Marissa Watson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Historique de carrière de Marissa Watson
Anciens postes connus de Marissa Watson
Sociétés | Poste | Début | Fin |
---|---|---|---|
NEUROTROPE, INC. | Comptroller/Controller/Auditor | 15/05/2012 | 20/06/2013 |
Directeur/Membre du Conseil | 15/05/2012 | 20/06/2013 | |
Directeur Financier/CFO | 15/05/2012 | 20/06/2013 | |
President | 15/05/2012 | 20/06/2013 | |
Secrétaire Général | 15/05/2012 | 20/06/2013 | |
Treasurer | 15/05/2012 | 20/06/2013 |
Statistiques
Internationale
Etats-Unis | 2 |
Opérationnelle
Comptroller/Controller/Auditor | 1 |
Director/Board Member | 1 |
Director of Finance/CFO | 1 |
Sectorielle
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Neurotrope, Inc.
![]() Neurotrope, Inc. Pharmaceuticals: MajorHealth Technology Neurotrope, Inc. is a biopharmaceutical company, which engages in the pre-clinical and clinical development of its product candidates. The company focuses on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease. It also develops bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X and Niemann-Pick Type C. The company was founded on January 11, 2011 and is headquartered in New York, NY. | Health Technology |
- Bourse
- Insiders
- Marissa Watson
- Expérience